Annual review 2024-2025
We’re pleased to share the first-year progress of C-Further. Since its official launch in September 2024, we’ve established the foundations of a child-first drug discovery organisation, focused on tackling the key bottlenecks in childhood cancer therapeutic development.
Over the past year, we’ve run 3 project calls and welcomed Great Ormond Street Hospital Charity as a new partner — bringing our total funding to approximately £37 million (USD 50 million).
Just as importantly, we’ve built connections with an international network of researchers, drug discovery scientists, impact investors, and industry partners — who are ready and committed to driving change in a sector that has long been held back.
Read more about our progress in our first annual review:
